Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 1, 2005 - Issue 2
120
Views
8
CrossRef citations to date
0
Altmetric
REGULAR ARTICLES

Pharmacologic Treatments for Co-Occurring Substance Use Disorders in Patients with Schizophrenia

A Research Review

, , &
Pages 41-55 | Published online: 20 Nov 2008

References

  • Kendler , K. S. , Gallagher , T. J. Abelson , J. M. 1996 . Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: The national comorbidity survey . Arch Gen Psychiatry , 53 ( 11 ) : 1022 – 1031 .
  • Regier , D. A. , Farmer , M. E. Rae , D. S. 1990 . Comorbidity of mental disorders with alcohol and other drug abuse . JAMA , 264 : 2511 – 2518 .
  • Drake , R. E. and Mueser , K. T. 1996 . Alcohol-use disorder and severe mental illness . Alcohol Health Res World , 20 : 87 – 93 .
  • Mueser , K. T. , Yarnold , P. R. Levinson , D. F. 1990 . Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates . Schizophr Bull , 16 : 31 – 56 .
  • Selzer , J. A. and Lieberman , J. A. 1993 . Schizophrenia and substance abuse . Psychiatr Clin North Am , 16 : 401 – 412 .
  • Rolfe , T. J. , McGory , P. Cooks , J. 1999 . Cannabis use in first episode psychosis: Incidence and short-term outcome . Schizophr Res , 36 : 313
  • Dalack , G. W. , Healy , D. J. and Meador-Woodruff , J. H. 1998 . Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings . Am J Psychiatry , 155 : 1490 – 1501 .
  • Hughes , J. R. , Hatsukami , D. K. Mitchell , J. E. 1986 . Prevalence of smoking among schizophrenic outpatients . Am J Psychiatry , 143 : 993 – 997 .
  • Drake , R. E. and Wallach , M. A. 1993 . Moderate drinking among people with severe mental illness . Hosp Community Psychiatry , 44 : 780 – 782 .
  • Owen , R. R. , Fischer , E. P. Booth , B. M. 1996 . Medication noncompliance and substance abuse among patients with schizophrenia . Psychiatr Serv , 47 ( 8 ) : 853 – 8 .
  • Swofford , C. D. , Kasckow , J. W. Scheller-Gilkey , G. 1996 . Substance use: A powerful predictor of relapse in schizophrenia . Schizophr Res , 20 : 145 – 151 .
  • Haywood , T. W. , Kravitz , H. M. Grossman , L. S. 1995 . Predicting the revolving door phenomenon among patients with schizophrenic, schizoaffective, and affective disorders . Am J Psychiatry , 152 : 856 – 861 .
  • Swartz , M. S. , Swanson , J. W. Hiday , V. A. 1998 . Violence and mental illness: The effects of substance abuse and nonadherence to medication . Am J Psychiatry , 155 : 226 – 231 .
  • Goodman , L. A. , Rosenberg , S. D. Mueser , K. T. 1997 . Physical and sexual assault history in women with serious mental illness: Prevalence, correlates, treatment, and future research directions . Schizophr Bull , 23 ( 4 ) : 685 – 96 .
  • Neria , Y. , Bromet , E. J. Sievers , S. 2002 . Trauma exposure and posttraumatic stress disorder in psychosis: Findings from a first-admission cohort . J Consult Clin Psychol , 70 ( 1 ) : 246 – 251 .
  • Rosenberg , S. D. , Goodman , L. A. Osher , F. C. 2001 . Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness . Am J Public Health , 91 : 31 – 37 .
  • Abram , K. M. and Teplin , L. A. 1991 . Co-occurring disorders among mentally ill jail detainees . Am Psychol , 46 : 1036 – 1044 .
  • Hurlburt , M. S. , Hough , R. L. and Wood , P. A. 1996 . Effects of substance abuse on housing stability of homeless mentally ill persons in supported housing . Psychiatr Serv , 47 : 731 – 736 .
  • Addington , J. 1999 . Early intervention strategies for co-morbid cannabis use and psychosis . Inaugural International Cannabis and Psychosis Conference. . 1999 , Melbourne.
  • Green , A. I. , Tohen , M. Hamer , R. M. 2004 . First episode schizophrenia-related psychosis and substance use disorders: Acute response to olanzapine and haloperidol . Schizophr Res , 66 ( 2–3 ) : 125 – 135 .
  • Deganhardt , L. , Hall , W. and Lynskey , M. 2003 . Testing hypotheses about the relationship between cannabis use and psychosis . Drug Alcohol Depend , 71 : 37 – 48 .
  • Lieberman , J. , Kane , J. and Alvir , J. 1987 . Provocative tests with psychostimulant drugs in schizophrenia . Psychopharmacology (Berl) , 91 ( 4 ) : 415 – 433 .
  • Drake , R. E. , Osher , F. C. and Wallach , M. A. 1989 . Alcohol use and abuse in schizophrenia: A prospective community study . J Nerv Ment Dis , 177 : 408 – 414 .
  • Treffert , D. A. 1978 . Marijuana use in schizophrenia: A clear hazard . Am J Psychiatry , 135 ( 10 ) : 1213 – 1215 .
  • Khantzian , E. J. 1997 . The self-medication hypothesis of substance use disorders: A reconsideration and recent applications . Harv Rev Psychiatry , January/February : 231 – 244 .
  • Siris , S. 1990 . Pharmacological treatment of substance-abusing schizophrenic patients . Schizophr Bull , 16 : 111 – 122 .
  • Addington , J. and Addington , D. 1998 . Effect of substance misuse in early psychosis . Br J Psychiatry Suppl , 172 ( 33 ) : 134 – 6 .
  • Buckley , P. , Thompson , P. Way , L. 1994 . Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy . Am J Psychiatry , 151 : 385 – 389 .
  • Glynn , S. H. and Sussman , S. 1990 . Why patients smoke . Hosp Community Psychiatry , 41 : 1027 – 1028 .
  • Kavanagh , D. J. , Waghorn , G. Jenner , L. 2004 . Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiologic sample . Schizophr Res , 66 : 115 – 124 .
  • Lysaker , P. H. , Bell , M. D. Beam-Goulet , J. 1994 . Relationship of positive and negative symptoms to cocaine abuse in schizophrenia . J Nerv Ment Dis , 182 : 109 – 112 .
  • Yang , Y. K. , Nelson , L. Kamaraju , L. 2002 . Nicotine decreases bradykinesia-rigid-ity in Haloperidol-treated patients with schizophrenia . Neuropsychopharmacology , 27 : 684 – 686 .
  • Brunette , M. , Mueser , K. T. Drake , R. E. 1997 . Relationships between symptoms of schizophrenia and substance abuse . J Nerv Ment Dis , 185 : 13 – 20 .
  • Hamera , E. , Schneider , J. K. and Stanley , S. 1995 . Alcohol, cannabis, nicotine, and caffeine use and symptoms distress in schizophrenia . J Nerv Ment Dis , 183 : 559 – 565 .
  • Buchanan , R. W. , Strauss , M. E. Breier , A. 1997 . Attentional impairments in deficit and nondeficit forms of schizophrenia . Am J Psychiatry , 154 : 363 – 370 .
  • Soni , S. and Brownlee , M. 1991 . Alcohol abuse in chronic schizophrenics: Implications for management in the community . Acta Psychiatr Scand , 84 : 272 – 276 .
  • Green , A. I. , Salomon , M. Brenner , M. 2002 . Treatment of schizophrenia and comorbid substance use disorder . Curr Drug Target CNS Neurol Disord , 1 : 129 – 139 .
  • McEvoy , J. and Brown , C. 1999 . Smoking in first-episode patients with schizophrenia . Am J Psychiatry , 156 ( 7 ) : 1120 – 1121 .
  • Veen , N. D. , Selten , J. van der Tweel , I. 2004 . Cannabis use and age at onset of schizophrenia . Am J Psychiatry , 161 : 501 – 506 .
  • Noordsy , D. L. , Drake , R. E. Biesanz , J. C. 1994 . Family history of alcoholism in schizophrenia . J Nerv Ment Dis , 182 : 651 – 655 .
  • Bidaut-Russell , M. , Bradford , S. E. and Smith , E. M. 1994 . Prevalence of mental illnesses in adult offspring of alcoholic mothers . Drug Alcohol Depend , 35 ( 2 ) : 81 – 90 .
  • Jones , P. and Cannon , M. 1998 . The new epidemiology of schizophrenia . Psychiatr Clin North Am , 21 ( 1 ) : 1 – 25 .
  • Kendler , K. S. 1985 . A twin study of individuals with both schizophrenia and alcoholism . Br J Psychiatry , 147 : 48 – 53 .
  • Kendler , K. S. , Masterson , C. C. and Davis , K. L. 1985 . Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness . Br J Psychiatry , 147 : 524 – 31 .
  • Kendler , K. S. , O'Neill , F. A. Burke , J. 1996 . Irish study of high-density schizophrenia families: Field methods and power to detect linkage . AACN Clin Issues , 67 : 179 – 190 .
  • Kendler , K. S. , Karkowski-Shuman , L. and Walsh , D. 1996 . The risk for psychiatric illness in siblings of schizophrenics: The impact of psychotic and non-psychotic affective illness and alcoholism in parents . Acta Psychiatr Scand , 94 : 49 – 55 .
  • Green , A. I. , Zimmet , S. V. Strous , R. D. 1999 . Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? . Harv Rev Psychiatry , 6 : 287 – 296 .
  • Stone , W. S. , Faraone , S. V. Seidman , L. J. 2001 . Concurrent validation of schizaotaxia: A pilot study . Biol Psychiatry , 50 : 434 – 440 .
  • Chambers , R. A. and Self , D. W. 2002 . Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: An animal model of dual diagnosis schizophrenia . Neuropsychopharmacology , 2 : 889 – 905 .
  • Chambers , A. R. , Krystal , J. H. and Self , D. W. 2001 . A neurobiological basis for substance abuse comorbidity in schizophrenia . Biol Psychiatry , 50 : 71 – 83 .
  • Fadda , F. , Mosca , E. Colombo , G. 1989 . Effects of spontaneous ingestion of etha-nol on brain dopamine metabolism . Life Sci , 44 : 281 – 287 .
  • Goeders , N. E. and Smith , J. E. 1986 . Reinforcing properties of cocaine in the medial prefrontal cortex: Primary action on presynaptic dopaminergic terminals . Pharmacol Biochem Behav , 25 : 191 – 199 .
  • Dervaux , A. , Bayle , F. Laqueille , X. 2001 . Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? . Am J Psychiatry , 158 ( 3 ) : 492 – 494 .
  • Drake , R. E. , Mueser , K. T. Brunette , M. F. 2004 . A review of treatment for clients with severe mental illness and co-occurring substance use disorders . Psychosoc Rehab J ,
  • Barrowclough , C. , Haddock , G. Tarrier , N. 2001 . Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders . Am J Psychiatry , 158 : 1706 – 1713 .
  • Blankertz , L. E. and Cnaan , R. A. 1994 . Assessing the impact of two residential programs for dually diagnosed homeless individuals . Soc Serv Rev , 68 : 536 – 560 .
  • Drake , R. E. , McHugo , G. J. Clark , R. E. 1998 . Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: A clinical trial . Am J Orthopsychiatry , 68 : 201 – 215 .
  • Brunette , M. F. , Drake , R. E. Lynde , D. 2002 . Toolkit for integrated dual disorders treatment, Substance Abuse and Mental Health Services Administration
  • Mueser , K. T. , Noordsy , D. L. Drake , R. E. 2003 . Integrated Treatment for Dual Disorders: A Guide to Effective Practice , New York : Guilford Publications .
  • Krystal , J. H. , D'Souza , D. C. Madonick , S. 1999 . Toward a rational pharmaco-therapy of comorbid substance abuse in schizophrenic patients . Schizophr Res , 35 : 35 – 49 .
  • Noordsy , D. L. and Green , A. I. 2003 . Pharmacotherapy for schizophrenia and co-occurring substance use disorders . Curr Psychiatry Rep , 5 ( 5 ) : 340 – 6 .
  • Wilkins , J. N. 1997 . Pharmacotherapy of schizophrenia patients with comorbid substance abuse . Schizophr Bull , 23 : 215 – 228 .
  • Noordsy , D. L. , Torrey , W. C. Mueser , K. T. 2002 . Recovery from severe mental illness: An intrapersonal and functional outcome definition . Int Rev Psychiatry , 14 : 318 – 326 .
  • Salyers , M. P. and Mueser , K. T. 2001 . Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia . Schizophr Res , 48 : 109 – 123 .
  • McEvoy , J. P. , Freudenreich , O. Levin , E. 1995 . Haloperidol increases smoking in patients with schizophrenia . Psychopharmacology (Berl) , 119 : 124 – 126 .
  • Buckley , P. , McCarthy , M. Chapman , P. 1999 . Clozapine treatment of comorbid substance abuse in patients with schizophrenia . Schizophr Res , 36 : 272
  • Drake , R. E. , Xie , H. McHugo , G. J. 2000 . The effects of clozapine on alcohol and drug use disorders among schizophrenic patients . Schizophr Bull , 26 : 441 – 449 .
  • Green , A. I. , Burgess , E. S. Zimmet , S. V. 2003 . Alcohol and cannabis use in schizophrenia: Effects of clozapine and risperidone . Schizophr Res , 60 : 81 – 85 .
  • Lee , M. L. 1998 . Clozapine and substance abuse in patients with schizophrenia . Can J Psychiatry , 45 : 855 – 856 .
  • Zimmet , S. V. , Strous , R. D. Burgess , E. S. 2000 . Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey . J Clin Psychopharmacol , 20 : 94 – 98 .
  • George , T. P. , Sernyak , M. J. Ziedonis , D. 1996 . Effects of clozapine on smoking in chronic schizophrenic outpatients . J Clin Psychiatry , 57 : 4 – 11 .
  • McEvoy , J. P. , Freudenreich , O. McGee , M. 1995 . Clozapine decreases smoking in patients with chronic schizophrenia . Biol Psychiatry , 37 : 550 – 552 .
  • McEvoy , J. , Freudenreich , O. McGee , M. 1999 . Smoking and therapeutic response to clozapine in patients with schizophrenia . Biol Psychiatry , 46 : 125 – 129 .
  • Albanese , M. J. 2000 . Risperidone in substance abusers with bipolar disorder. . 39th Annual Meeting of the American College of Neuropsychopharmacology. . 2000 , San Juan, Puerto Rico.
  • Smelson , D. , Losonczy , M. Davis , C. W. 2002 . Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence . Can J Psychiatry , 47 ( 7 ) : 671 – 675 .
  • Littrell , K. H. , Petty , R. G. Hilligoss , N. 2001 . Olanzapine treatment for patients with schizophrenia and substance abuse . J Sbst Abuse Treat , 21 : 217 – 221 .
  • Noordsy , D. L. , O'Keefe , C. D. Mueser , K. T. 2001 . Six-month outcomes for patients who switched to olanzapine treatment . Psychiatr Serv , 52 : 501 – 507 .
  • Brown , E. S. , Nejtek , V. A. and Perantie , D. C. 2002 . Neuroleptics and quetiapine in psychiatric illness with comorbid stimulant abuse . 57th Annual Convention of the Society of Biological Psychiatry. . 2002 , Philadelphia, Pennsylvania.
  • George , T. P. , Ziedonis , D. M. Feingold , A. 2000 . Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia . Am J Psychiatry , 157 : 1835 – 1842 .
  • Brady , K. T. , Myrick , H. and Henderson , S. 2002 . Divalproex in the prevention of relapse to alcohol use . Drug Alcohol Depend , 67 : 323 – 330 .
  • Myrick , H. , Henderson , S. Brady , K. T. 2001 . Gabapentin in the treatment of cocaine dependence: A case series . J Clin Psychiatry , 1 : 19 – 23 .
  • Casey , D. E. , Daniel , D. G. Wassef , A. A. 2003 . Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia . Neuropsychopharmacology , 28 : 182 – 192 .
  • Citrome , L. 2003 . Schizophrenia and valproate . Psychopharmacol Bull , 37 ( suppl 2 ) : 74 – 88 .
  • Hertzman , M. 2002 . Divalproex sodium to treat concomitant abuse and mood disorders . J Subst Abuse Treat , 18 : 371 – 372 .
  • Brady , K. T. and Sonne , S. C.R. A. 1995 . Valproate in the treatment of acute bipolar affective episodes by substance abuse: A pilot study . J Clin Psychiatry , 56 : 118 – 121 .
  • Jablonowski , K. , Margolese , H. C. and Chouinard , G. 2002 . Gabapentin-induced paradoxidal exacerbation of psychosis in a patient with schizophrenia . Can J Psychiatry , 47 : 975 – 976 .
  • Petroff , O. A. , Hyder , F. Rothman , D. L. 2001 . Topiramate rapidly raises brain GABA in epilepsy patients . Epiloepsia , 42 ( 4 ) : 543 – 548 .
  • Johnson , B. A. , Ait-Daoud , N. and Bowden , C. L. 2003 . Oral topiramate for treatment of alcohol dependence: A randomized controlled trial . The Lancet , 361 : 1677 – 1685 .
  • Millson , R. C. , Owen , J. A. Lorberg , G. W. 2002 . Topiramate for refractory schizophrenia . Am J Psychiatry , 159 : 675
  • Drapalski , A. L. , Rosse , R. B. Peebles , R. R. 2001 . Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication . Clinical Neuropsychopharmacology , 24 ( 5 ) : 290 – 294 .
  • Evins , A. E. , Mayes , V. K. Rigottie , N. A. 2001 . A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessationin schizophrenia . Nicotine Tob Res , 3 : 397 – 403 .
  • George , T. P. , Vessicchio , J. C. Termine , A. 2002 . A placebo controlled trial of bupropion for smoking cessation in schizophrenia . Biol Psychiatry , 52 : 53 – 61 .
  • Weiner , E. , Ball , M. P. Summerfelt , A. 2001 . Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia . Am J Psychiatry , 158 : 635 – 637 .
  • Siris , S. G. , Mason , S. E. Bermanzohn , P. C. 1993 . Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients . Psychopharmacol Bull , 29 : 127 – 133 .
  • Ziedonis , D. , Richardson , T. Lee , E. 1992 . Adjunctive desipramine in the treatment of cocaine abusing schizophrenics . Psychopharmacol Bull , 28 : 309 – 314 .
  • Clark , R. E. , Xie , H. and Brunette , M. 2004 . Benzodiazepine prescription practices and substance abuse in persons with schizophrenia . J Clin Psychiatry ,
  • Brunette , M. , Noordsy , D. L. Xie , H. 2003 . Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders . Psychiatr Serv , 54 ( 10 ) : 1395 – 1401 .
  • Kofoed , L. L. , Kania , J. Walsh , T. 1986 . Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders . Am J Psychiatry , 143 : 867 – 872 .
  • Kingsbury , S. J. and Salzman , C. 1990 . Disulfiram in the treatment of alcoholic patients with schizophrenia . Hosp Community Psychiatry , 41 : 133 – 134 .
  • Mueser , K. T. , Noordsy , D. L. Fox , M. 2003 . Disulfiram treatment for alcoholism in severe mental illness . Am J Addict , in press
  • Dougherty , R. J. 1997 . Naltrexone in the treatment of alcohol dependent dual diagnosed patients . J Addict Dis , 16 : 107
  • Maxwell , S. and Shinderman , M. S. 2000 . Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness . J Addict Dis , 19 ( 3 ) : 61 – 9 .
  • Maxwell , S. and Shinderman , M. S. 1997 . Naltrexone in the treatment of dually diagnosed patients . J Addict Dis , 16 : 125
  • Petrakis , I. L. , O'Malley , S. S. Rounsaville , B. 2004 . Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia . Psycho-pharmacology (Berl) , 172 : 291 – 297 .
  • O'Malley , S. S. , Jaffe , A. J. Chang , G. 1992 . Naltrexone and coping skills therapy for alcohol dependence: A controlled study . Arch Gen Psychiatry , 49 : 881 – 887 .
  • Volpicelli , J. R. , Alterman , A. I. Hayashida , M. 1992 . Naltrexone in the treatment of alcohol dependence . Arch Gen Psychiatry , 49 : 876 – 887 .
  • Mattick , R. , Breen , C. Kimber , J. 2004 . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence . The Cochrane Database of Systematic Reviews , 2
  • Miotto , P. , Preti , A. and Frezza , M. 2001 . Heroin and schizophrenia: Subjective responses to abused drugs in dually diagnosed patients . J Clin Psychopharmacol , 21 ( 1 ) : 111 – 113 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.